Patricia Sheehy

MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia

Steven P. Treon, Lian Xu, Guang Yang et al. · New England Journal of Medicine · 2012 · 1.3K citations · Full text

Medicine, Hematology, Molecular Genetics +15

The genomic landscape of Waldenström macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis

Zachary R. Hunter, Lian Xu, Guang Yang et al. · Blood · 2013 · 480 citations

Life Sciences, Genetics, Molecular Genetics +15

Primary Therapy of Waldenström Macroglobulinemia With Bortezomib, Dexamethasone, and Rituximab: WMCTG Clinical Trial 05-180

Steven P. Treon, Leukothea Ioakimidis, Jacob D. Soumerai et al. · Journal of Clinical Oncology · 2009 · 290 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemia

Steven P. Treon, Christina Tripsas, Kirsten Meid et al. · Blood · 2014 · 177 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +4

Bendamustine Therapy in Patients With Relapsed or Refractory Waldenström's Macroglobulinemia

Steven P. Treon, Christina Hanzis, Christina Tripsas et al. · Clinical Lymphoma Myeloma & Leukemia · 2011 · 104 citations

Medicine, Oncology, Pharmacotherapy +4